75 related articles for article (PubMed ID: 18396669)
1. [Detection of serum anti-F antibody in hepatitis C virus infected patients].
Deng XZ; Jiang CM; Xu K; Wang ZC; Ding WL; Yu RB; Wang J; Wu C; Zhang Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Nov; 28(11):1116-8. PubMed ID: 18396669
[TBL] [Abstract][Full Text] [Related]
2. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
3. [Antigenicity of hepatitis C virus F protein and serum prevalence of anti-F in HCV-infected patients].
Shao SW; Wu WB; Yu JG; Zhao P; Qi ZT
Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):890-3. PubMed ID: 17196130
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of the detection of hepatitis C virus core antigen].
Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
[TBL] [Abstract][Full Text] [Related]
5. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia.
Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R
Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
[TBL] [Abstract][Full Text] [Related]
8. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide].
Sugiyasu T
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
10. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
11. Clinical importance of assessment of anti-HCV IgM antibodies in chronic hepatitis C.
Stránský J; Honzáková E; Vandasová J; Horejsová M; Kyncl J; Nĕmecek V; Horák J
Acta Virol; 1996 Apr; 40(2):61-5. PubMed ID: 8886113
[TBL] [Abstract][Full Text] [Related]
12. [Virological studies on the usefulness of anti-HCV ELISA assay using recombinant N-14 fusion protein in various liver diseases].
Imamura S
Fukuoka Igaku Zasshi; 1993 Apr; 84(4):138-47. PubMed ID: 7686126
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
Tanaka K; Hirohata T; Koga S; Sugimachi K; Kanematsu T; Ohryohji F; Nawata H; Ishibashi H; Maeda Y; Kiyokawa H
Cancer Res; 1991 Jun; 51(11):2842-7. PubMed ID: 1851661
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of hepatitis C virus infection to alcoholics with cirrhosis in Korea.
Kwon SY; Ahn MS; Chang HJ
J Gastroenterol Hepatol; 2000 Nov; 15(11):1282-6. PubMed ID: 11129222
[TBL] [Abstract][Full Text] [Related]
16. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
17. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
Bode JC; Alscher DM; Wisser H; Bode C
Alcohol Alcohol; 1995 Jan; 30(1):97-103. PubMed ID: 7748281
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C infection in BMT patients.
Kolho E; Ruutu P; Ruutu T
Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]